ClinicalTrials.gov
ClinicalTrials.gov Menu

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation (TeleTx)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00536926
Recruitment Status : Completed
First Posted : September 28, 2007
Last Update Posted : July 20, 2011
Sponsor:
Collaborator:
Corscience, Inc.
Information provided by:
Hannover Medical School

Brief Summary:
In an investigation should be evaluated in contrast to a control group with standard post-treatment therapy (using home spirometry) after lung transplantation if transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy.

Condition or disease Intervention/treatment Phase
Lung Transplantation Device: Home spirometry with data transfer via cell phone Device: Home spirometer with BT-cellphone Device: Home spirometer w/o BT Phase 3

Detailed Description:

Home spirometry is used as a standard of care in lung transplant recipients in many centers worldwide. In case of deteriorating lung function response until therapy depends on patients efforts to reach the transplant center and the contactability of the transplant center.

Therefore transfer of home spirometry recordings to the transplant center via cell phones will lead to less complications, cost savings and bigger constancy of therapy compared to the home spirometry alone.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 56 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation - an Open, Randomised Trial
Study Start Date : July 2007
Actual Primary Completion Date : November 2008
Actual Study Completion Date : July 2009

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: A
home spirometry alone
Device: Home spirometer w/o BT
Standard home spirometry
Other Name: Viasys (Jaeger, Germany) AM1

Experimental: B
Home spirometry with data transfer via cellphone to clinical database
Device: Home spirometry with data transfer via cell phone
home spirometry recording
Other Names:
  • Viasys AM1 /group A
  • Viasys AM1+BT/ group B

Device: Home spirometer with BT-cellphone
Data transfer of home spirometry recordings via bluetooth to clinical database.
Other Name: Viasys AM1 BT (Jaeger, Germany) with BT-cellphone




Primary Outcome Measures :
  1. Adherence [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Latency: symptom onset to transplant team contact patient contacts emergency visits hospitalisations [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients after lung transplantation (single and double lung transplantation incl. combined organ transplantation) before hospital discharge

Exclusion Criteria:

  • Dependency on long term care
  • Restricted ability to communicate

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00536926


Locations
Germany
Hannover Medical School, Dpt. resiratory Medicine OE6870
Hannover, Germany, 30625
Sponsors and Collaborators
Hannover Medical School
Corscience, Inc.
Investigators
Principal Investigator: Jens Gottlieb, MD Dpt. Respiratory Medicine

Publications of Results:
Responsible Party: Jens Gottlieb, M.D., Hannover Medical School
ClinicalTrials.gov Identifier: NCT00536926     History of Changes
Other Study ID Numbers: 124
First Posted: September 28, 2007    Key Record Dates
Last Update Posted: July 20, 2011
Last Verified: October 2008

Keywords provided by Hannover Medical School:
telemedicine
lung transplantation
home spirometry